Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: health – Page 320

Schizophrenia is a severe mental health condition that causes significant disability, and affects 1 in 100 people. Patients with schizophrenia commonly experience negative symptoms, which include lack of motivation, social isolation and inability to experience pleasurable feeling. The current antipsychotics minimally improve these negative symptoms, and there are no currently licensed treatments. In addition, it is estimated that total service costs for schizophrenia in England alone will be £6.5 billion by 2026. In view of this, there is considerable interest in identifying potential treatment targets for these symptoms. However, the nature of the changes in brain chemistry that contribute to these negative symptoms is unknown.

Mu-opioid receptors (MOR) are found in a region of the called the striatum and they play a crucial role in how we experience pleasure and reward. Our bodies naturally produce opioid molecules that include endorphins; which are hormones secreted by the brain that are known to help relieve pain or stress and boost happiness. MORs are receptors that bind these naturally produced endogenous opioid molecules, and stimulation of the MOR system starts a signalling cascade that causes an increase in motivation to seek reward and increase food palatability amongst many other effects. Interestingly, MORs were found to be reduced in the striatum post-mortem in schizophrenia. So, it was unclear whether the availability of these receptors was increased when individuals were alive, or whether reduced MORs was related to the negative symptoms of schizophrenia.

The latest brain scan research from the Psychiatric Imaging group at the MRC LMS published on 3 October in Nature Communications has reported how the MOR system contributes to the negative symptoms displayed in schizophrenia patients. For the first time, this research study showed how MOR levels are significantly reduced in the striatum region of the brain. Thus, a lack of MOR system stimulation in the brain contributes to these negative feelings that schizophrenia patients can experience.

Read more | >

A new study is the first to report evidence that nonsteroidal anti-inflammatory drugs (NSAIDs) like aspirin may lessen the adverse effects of air pollution exposure on lung function. The team of researchers from the Columbia Mailman School of Public Health, Harvard Chan School of Public Health, Boston University School of Medicine published their findings in the American Journal of Respiratory and Critical Care Medicine.

The researchers analyzed a subset of data collected from a cohort of 2,280 male veterans from the greater Boston area who were given tests to determine their lung function. The average age of participants was 73 years. The researchers examined the relationship between test results, self-reported NSAID use, and ambient particulate matter (PM) and black carbon in the month preceding the test, while accounting for a variety of factors, including the health status of the subject and whether or not he was a smoker. They found that the use of any NSAID nearly halved of the effect of PM on lung function, with the association consistent across all four weekly air pollution measurements from same-day to 28 days prior to the lung function test.

Because most of the people in the study cohort who took NSAIDs used aspirin, the researchers say the modifying effect they observed was mainly from aspirin, but add that effects of non-aspirin NSAIDs are worthy of further exploration. While the mechanism is unknown, the researchers speculate that NSAIDs mitigate inflammation brought about by air pollution.

Read more | >

The fruit flies in Noah Whiteman’s lab may be hazardous to your health.

Whiteman and his University of California, Berkeley, colleagues have turned perfectly palatable —palatable, at least, to frogs and birds—into potentially poisonous prey that may cause anything that eats them to puke. In large enough quantities, the flies likely would make a human puke, too, much like the emetic effect of ipecac syrup.

That’s because the team genetically engineered the flies, using CRISPR-Cas9 gene editing, to be able to eat milkweed without dying and to sequester its toxins, just as America’s most beloved butterfly, the , does to deter predators.

Read more | >

A role for the gut microbiome on the health and functioning of many tissues, including the brain, liver, kidney, and adiposity, has been widely reported in the literature. Interestingly, 2019 might be the year that the role of the gut microbiome on skeletal muscle (i.e. the gut-muscle axis) comes into greater focus.

The influence of the gut microbiome on muscle strength

In April, Nay et al. reported that endurance exercise capacity was reduced in mice that do not contain a microbiome (germ-free mice, GFM) when compared with conventionally raised, microbiome-containing mice. This finding suggests that there are microbes in the gut that positively influence aerobic exercise performance.

Read more | >

The trawl found 20,500 articles tackling the topic, but shockingly, less than 1 percent of them were scientifically robust enough to be confident in their claims, say the authors. Of those, only 25 tested their deep learning models on unseen data, and only 14 actually compared performance with health professionals on the same test sample.

Nonetheless, when the researchers pooled the data from the 14 most rigorous studies, they found the deep learning systems correctly detected disease in 87 percent of cases, compared to 86 percent for healthcare professionals. They also did well on the equally important metric of excluding patients who don’t have a particular disease, getting it right 93 percent of the time compared to 91 percent for humans.

Ultimately, then, the results of the review are broadly positive for AI, but damning of the hype that has built up around the technology and the research practices of most of those trying to apply it to medical diagnosis.

Read more | >

  • A recent report by the World Health Organization (WHO) claims 2.6 million people die every year in middle and low-income countries from incorrect medical care.
  • The report, which was published before the first-ever World Patient Safety Day on September 17, reveals that five people die every minute from incorrect medical care.
  • The health agency says the most common errors occur in diagnosis, prescription and use of medicines and that the deaths are completely preventable.
  • The cost of prescribing the wrong medication alone is $42 billion a year.
  • Visit Business Insider’s homepage for more stories.

Every year, 2.6 million people die in middle and low-income countries because of incorrect medical care, according to a recent report published by the World Health Organization (WHO). The health agency is hoping to shed light on the issue by launching a campaign in solidarity with patients on the first-ever World Patient Safety Day on September 17.

“No one should be harmed while receiving health care. And yet globally, at least 5 patients die every minute because of unsafe care,” said Dr. Tedros Adhanom Ghebreyesus, WHO Director-General.

Read more | >